NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Phylos Bioscience

Phylos Bioscience

Private
Portland, OregonHealthcare & Life Scienceshttps://phylos.bio/

Last Round

Debt

Dec 31, 2025

Total Funding Raised

$29.35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Phylos Bioscience is a crop science company that develops and sells advanced cannabis and hemp genetics, including F1 hybrid seeds and natural THCV products, to empower growers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

cannabis geneticsgenomic breedingcannabis seedsmolecular diagnosticsgenetic testingF1 hybrid seedscultivar developmentcannabis techagtechplant genomicsweed sciencecannabis breedingseed geneticsbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phylos Bioscience Comparables

Compare Phylos Bioscience with similar companies based on industry and business-model similarity.

Phylos Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medicinal Genomics
84%
MyFloraDNA, Inc.
83%
Segra International
83%

Phylos Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 31, 2025
StrategicDec 31, 2024
Seed RoundJan 24, 2024
Convertible DebtMay 25, 2023
Series BFeb 1, 2022
VC Round
May 29, 2018

Key People

Founding team and executive leadership

Nishan Karassik

Chief Innovation Officer, Founder

Founding Team

Ralph Risch

Chief Executive Officer

Executive Team

Barbara Peachey

Chief Financial Officer

Executive Team

Phylos Bioscience Investors

Notable investors and investment history

Phylos Bioscience investors
InvestorRounds
AccompliceSeries B
Entourage Effect CapitalSeries B
Merida Capital PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 31, 2025

    $10M round led by Organigram Global Inc.

  • Jan 24, 2024

    $4.5M round raised

Phylos Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phylos Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phylos Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersPortland, Oregon
Employee Range50
Year Founded2014
Last FundingDec 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.